Table 2.
Hazard ratio (95% CI) | |
---|---|
ITT analysis (sorafenib vs. sorafenib + LRT) | 0.664 (0.544–0.812) |
ITT analysis, corrected for imbalances | 0.505 (0.407–0.628) |
As treated analysis (sorafenib vs. sorafenib + LRT) | 0.555 (0.453–0.681) |
Hazard ratio (95% CI) | |
---|---|
ITT analysis (sorafenib vs. sorafenib + LRT) | 0.664 (0.544–0.812) |
ITT analysis, corrected for imbalances | 0.505 (0.407–0.628) |
As treated analysis (sorafenib vs. sorafenib + LRT) | 0.555 (0.453–0.681) |